Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine
Status:
Completed
Trial end date:
2018-08-21
Target enrollment:
Participant gender:
Summary
This study is aimed at determining if the drug Atomoxetine (Strattera-used to treat Attention
Deficit Hyperactivity Disorder(ADHD) has effects on the body's ability to defend itself
against low blood sugar.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore